Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Pesci

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
The Lancet. Respiratory Medicine|November 20, 2016
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort studyMelissa J McDonnell, Stefano Aliberti, Pieter C Goeminne, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Respiration; International Review of Thoracic Diseases|March 28, 2018
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary FibrosisSergio Harari, Antonella Caminati, Venerino Poletti, et al.
Respiration; International Review of Thoracic Diseases|September 13, 2021
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up StudyPaola Faverio, Fabrizio Luppi, Paola Rebora, et al.
The Journal of Rheumatology|September 22, 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With PolyangiitisEmma Rubenstein, Carla Maldini, Augusto Vaglio, et al.
The Clinical Respiratory Journal|January 25, 2019
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidoneSergio Harari, Antonella Caminati, Marco Confalonieri, et al.
Rheumatology (Oxford, England)|January 13, 2012
PTPN22 R620W polymorphism in the ANCA-associated vasculitidesDavide Martorana, Federica Maritati, Giovanni Malerba, et al.
Respiratory Research|September 3, 2022
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approachPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
ERJ Open Research|March 10, 2022
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre studyPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The Lancet. Respiratory Medicine|November 20, 2016
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort studyMelissa J McDonnell, Stefano Aliberti, Pieter C Goeminne, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Respiration; International Review of Thoracic Diseases|March 28, 2018
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary FibrosisSergio Harari, Antonella Caminati, Venerino Poletti, et al.
Respiration; International Review of Thoracic Diseases|September 13, 2021
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up StudyPaola Faverio, Fabrizio Luppi, Paola Rebora, et al.
The Journal of Rheumatology|September 22, 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With PolyangiitisEmma Rubenstein, Carla Maldini, Augusto Vaglio, et al.
The Clinical Respiratory Journal|January 25, 2019
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidoneSergio Harari, Antonella Caminati, Marco Confalonieri, et al.
Rheumatology (Oxford, England)|January 13, 2012
PTPN22 R620W polymorphism in the ANCA-associated vasculitidesDavide Martorana, Federica Maritati, Giovanni Malerba, et al.
Respiratory Research|September 3, 2022
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approachPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
ERJ Open Research|March 10, 2022
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre studyPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
Pageof 9